Aarti Drugs to acquire Suyash Laboratories
|
6th May 2005: Aarti Drugs has decided to acquire a controlling stake in Suyash Laboratories, subject to necessary approvals from the appropriate authorities. The board of Aarti Drugs, at its meeting held yesterday, has decided to acquire a controlling stake in Suyash Laboratories thereby making it a 51% subsidiary of the company," Aarti Drugs said in a release issued to the NSE today. Suyash is engaged in the manufacture, sale and exports of active pharmaceutical ingredients (APIs) for cardiovascular, anti-fungal and anti-inflammatory drugs, the release added.
|
Tata Finance' equity shareholders & creditors approve Scheme of Reorganisation & Amalgamation
|
7th May 2005: Tata Finance Ltd has informed BSE that pursuant to the order of the High Court of Judicature at Mumbai dated March 18, 2005, the Secured Creditors, Unsecured Creditors & Equity Shareholders of the Company at the Court Convened Meetings held on April 26, 2005 have approved the Scheme of Reorganisation & Amalgamation of the Company with Tata Motors Ltd.
|
Strides Arcolab acquires 90% stake in Medgene Pharmaceuticals
|
5th May 2005: Strides Arcolab has acquired Hyderabad-based Medgene Pharmaceuticals by acquiring 90% equity stake in the company. According to a release issued by Strides to the NSE today, Medgene has become a subsidiary of the company with effect from May 3, 2005. "Medgene is engaged in the business of biotech and biopharmaceuticals," the release added. No financial details were released by Strides.
|
Click to view more 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 |